Inventor · disambiguated record
Noah Bell
Also filed as: BELL NOAH
20 granted patents·8 pending applications·60 citations·filing 2011–2025
93Inventor score
Top patents by PatentIndex Score
28 records- 0191US8541448B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersCHARMOT DOMINIQUE·Filed 2011·Granted Sep 24, 2013·6 cites·6 claims
- 0289US9408840B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorderARDELYX INC·Filed 2015·Granted Aug 9, 2016·6 cites·6 claims
- 0388US10543207B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2017·Granted Jan 28, 2020·3 cites·43 claims
- 0487US10376481B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2017·Granted Aug 13, 2019·3 cites·32 claims
- 0587US8969377B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2013·Granted Mar 3, 2015·3 cites·7 claims
- 0686US10968246B2Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonistsARDELYX INC·Filed 2019·Granted Apr 6, 2021·2 cites·27 claims
- 0786US8916569B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2013·Granted Dec 23, 2014·7 cites·44 claims
- 0886US8809339B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2013·Granted Aug 19, 2014·8 cites·36 claims
- 0985US8815910B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2013·Granted Aug 26, 2014·7 cites·38 claims
- 1085US8815908B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2013·Granted Aug 26, 2014·7 cites·32 claims
- 1184US11318129B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2020·Granted May 3, 2022·1 cites·19 claims
- 1283US10385024B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2018·Granted Aug 20, 2019·3 cites·36 claims
- 1381US12016856B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2022·Granted Jun 25, 2024·0 cites·2 claims
- 1481US9006281B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2013·Granted Apr 14, 2015·1 cites·15 claims
- 1580US10392413B2Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonistsARDELYX INC·Filed 2016·Granted Aug 27, 2019·3 cites·39 claims
- 1669US2024366590A1Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2024·Application pending·0 cites
- 1769US2025388615A9Substituted 4-phenyl pyridine compounds as non-systemic tgr5 agonistsARDELYX INC·Filed 2024·Application pending·0 cites
- 1863US2019374533A1Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2018·Application pending·0 cites
- 1962US9301951B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2014·Granted Apr 5, 2016·0 cites·40 claims
- 2058US9289429B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2014·Granted Mar 22, 2016·0 cites·33 claims
- 2158US9289430B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2014·Granted Mar 22, 2016·0 cites·35 claims
- 2258US9278102B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2014·Granted Mar 8, 2016·0 cites·29 claims
- 2358US2025367188A1Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2025·Application pending·0 cites
- 2456US12084472B2Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonistsARDELYX INC·Filed 2021·Granted Sep 10, 2024·0 cites·54 claims
- 2551US2015299131A1Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2013·Application pending·0 cites
- 2649US2017037010A1Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2016·Application pending·0 cites
- 2743US2015336892A1Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2013·Application pending·0 cites
- 2842US2014023611A1Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Noah Bell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →